Director, Early Development to Calliditas Therapeutics

Job description

About Us Calliditas Therapeutics is a biopharmaceutical company focused on identifying, developing, and commercializing novel treatments in orphan indications with significant unmet medical needs. Our lead compound, TARPEYO (budesonide), is the first FDA-approved treatment for IgA nephropathy. With an international presence and a strong growth trajectory, Calliditas is building a world-class team committed to advancing science and delivering innovative therapies that improve patients’ lives. The company culture is entrepreneurial, collaborative, and science-driven, with a strong belief in empowering employees and fostering cross-functional knowledge sharing. In 2024, Calliditas Therapeutics was acquired by Asahi Kasei corporation and the integration is ongoing. Position Summary: The Director, Early Development will play a key strategic role within the global Medical Affairs organization, responsible for shaping and executing medical strategy for early pipeline assets across multiple disease areas. Acting as a global scientific resource, you will drive high-impact scientific exchange with key opinion leaders, investigators, and external experts, while supporting the advancement of i...